|Articles|February 2, 2003
- Pharmaceutical Technology-02-02-2003
- Volume 27
- Issue 2
PhRMA Perspectives on Drug Substance Regulatory Filing Issues
Author(s)Michael Mitchell
The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.
Advertisement
Articles in this issue
almost 23 years ago
A Stress Testing Benchmarking Studyabout 23 years ago
Cleanroom Pressurization Methodologyabout 23 years ago
Manufacturing Capability Key to Global Health Advancesabout 23 years ago
February 2003about 23 years ago
Outsourcing OutlookNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Six New and Nine Indication Extension Recommendations from EMA’s CHMP
2
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
3
Women in STEM: Inspiration from Innovators in Pharma
4
EMA Recommends Rezurock for Chronic Graft-Versus-Host Disease
5